The Integrated Stress Response in Human Islets During Early T1D
The Integrated Stress Response in Human Islets During Early T1D
批准号:
10592566
负责人:
Thomas O Metz
金额:
$40.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2024-06-30
关键词:
AddressAffectAreaArtificial IntelligenceAutoimmunityBeta CellBiologicalBiological MarkersCell SurvivalCell physiologyCellular StressClinicalCollaborationsCommunitiesCommunity NetworksComputer softwareDataData SetDefectDevelopmentDevelopment PlansExperimental DesignsFeedbackGenerationsGrantHumanImmunologicsIndividualInflammationIngestionInsulin-Dependent Diabetes MellitusKnowledgeLeadLearningMachine LearningMeasurementMessenger RNAMetadataMethodsModelingMolecularMolecular ProfilingMonitorMultiomic DataOntologyPathogenesisPathway interactionsPhysicsProductionProteinsProteomicsPubMedPublicationsPublishingReadinessResearchResearch DesignResourcesRiskSample SizeScienceSignal PathwayStandardizationStressTechnologyTensorFlowTestingTractionTranslatingbasebiological adaptation to stressbiomarker discoverybiomarker panelbiomarker validationclassical conditioningcomputerized data processingdata repositoryfeature extractionheterogenous dataimprovedinsulin dependent diabetes mellitus onsetisletlearning communitylipidomicsmachine learning methodmachine learning modelminimally invasivemultidisciplinarymultiple omicsneoantigensnovelparent grantparent projectphrasespredictive modelingrapid growthrepositoryresponsesoftware developmentstress granuletrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The project, Integrated Stress Response in Human Islets During Early Type 1 Diabetes (T1D), hypothesizes that
the activation of the integrated stress response and formation of stress granules is an early cellular response
initiating β cell stress in T1D that determines cell survival and can be monitored in pre- and early-T1D individuals
with minimal invasiveness. A multidisciplinary Team science approach is being taken to test this hypothesis,
collecting a large suite of heterogenous data, such as mRNA, lipidomics, proteomics and immunologic
measurements. Machine learning is being used to extract a multi-biomarker panel to aid in stratifying stress in
human islets and translating these findings to individuals at-risk for T1D and new-onset T1D. Although we are
formatting the multi-omics data for this specific machine learning task within the parent grant, the data being
generated, as well as our data collected from prior collaborations, are not generally AI/ML-ready for general
application of methods. They are however excellent candidates to be used as “flagship” datasets for AI/ML
readiness, both to test novel AI/ML approaches to tackle data pre-processing challenges and to extract molecular
signatures of T1D. These two gaps in analyses are the central themes of two aims. The first aim focuses on the
generation of AI/ML ready omics datasets that are properly annotated to address challenges in sparsity and bias,
such as imputation and batch correction. The second aim focuses AI/ML ready multi-omic datasets to enable
new studies in using machine learning to elicit biomarkers and pathway-level molecular signatures from the data
focused on standard AI/ML methods, as well as those specialized for small sample size. Dataset machine
learning model cards will be utilized to better enable to AI/ML research communities to utilize these datasets in
an efficient manner. For both aims there is a key focus on generating reusable software approaches to generate
data packages that can be directly imported into the most common AI/ML packages and released to the AI/ML
community through a variety of resources that enable feedback to continually improve and refine the AI/ML
readiness software development plan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pacific Northwest Advanced Compound Identification Core
-
批准号:9769745
-
项目类别:
-
资助金额:$99.86万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Administrative Core
-
批准号:10213203
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:10260964
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:10213202
-
项目类别:
-
资助金额:$98.16万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:10012251
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Label-free polar metabolite quantification for untargeted metabolomics
-
批准号:10396924
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Next generation, 'Standards-Free' Metabolite Identification Pipeline
-
批准号:9433322
-
项目类别:
-
资助金额:$19.01万
-
财政年份:2017
-
负责人:Thomas O Metz
-
依托单位:
Validation of Novel Peptide/Protein Markers for Diagnosis of Type 1 Diabetes
-
批准号:8495451
-
项目类别:
-
资助金额:$92.38万
-
财政年份:2012
-
负责人:Thomas O Metz
-
依托单位:
Administrative Core
-
批准号:9769747
-
项目类别:
-
资助金额:$17.78万
-
财政年份:--
-
负责人:Thomas O Metz
-
依托单位:
海外基金